FI940637A - Karbakolia ja muita kolinergisiä substansseja sisältävä farmaseuttinenkoostumus - Google Patents

Karbakolia ja muita kolinergisiä substansseja sisältävä farmaseuttinenkoostumus Download PDF

Info

Publication number
FI940637A
FI940637A FI940637A FI940637A FI940637A FI 940637 A FI940637 A FI 940637A FI 940637 A FI940637 A FI 940637A FI 940637 A FI940637 A FI 940637A FI 940637 A FI940637 A FI 940637A
Authority
FI
Finland
Prior art keywords
carbacol
pharmaceutical composition
composition containing
cholinergic
cholinergic substances
Prior art date
Application number
FI940637A
Other languages
English (en)
Swedish (sv)
Other versions
FI108516B (fi
FI940637A0 (fi
Inventor
Rudolph Wolfgang Hahnenberger
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI940637A publication Critical patent/FI940637A/fi
Publication of FI940637A0 publication Critical patent/FI940637A0/fi
Application granted granted Critical
Publication of FI108516B publication Critical patent/FI108516B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
FI940637A 1991-08-13 1994-02-11 Menetelmä karbakolikloridia sisältävän farmaseuttisen valmisteen valmistamiseksi FI108516B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9102340A SE9102340D0 (sv) 1991-08-13 1991-08-13 Pharmaceutical composition containing carbachol and othercholinergic substances
SE9102340 1991-08-13
PCT/SE1992/000542 WO1993003718A1 (en) 1991-08-13 1992-08-07 Pharmaceutical composition containing carbachol and other cholinergic substances
SE9200542 1992-08-07

Publications (3)

Publication Number Publication Date
FI940637A true FI940637A (fi) 1994-02-11
FI940637A0 FI940637A0 (fi) 1994-02-11
FI108516B FI108516B (fi) 2002-02-15

Family

ID=20383456

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940637A FI108516B (fi) 1991-08-13 1994-02-11 Menetelmä karbakolikloridia sisältävän farmaseuttisen valmisteen valmistamiseksi

Country Status (14)

Country Link
US (1) US5679713A (fi)
EP (2) EP0661968B1 (fi)
JP (1) JPH06509801A (fi)
AT (1) ATE172114T1 (fi)
AU (1) AU671805B2 (fi)
CA (1) CA2114239C (fi)
DE (1) DE69227324T2 (fi)
DK (1) DK0661968T3 (fi)
ES (1) ES2123005T3 (fi)
FI (1) FI108516B (fi)
HU (1) HU221592B (fi)
NO (1) NO306447B1 (fi)
SE (1) SE9102340D0 (fi)
WO (1) WO1993003718A1 (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1127333C (zh) * 1997-02-24 2003-11-12 S.L.A.药业股份公司 含有胆碱能药物或钙通道阻滞剂的局部用医药组合物
WO1999007354A2 (en) * 1997-08-08 1999-02-18 Duke University Compositions, apparatus and methods for facilitating surgical procedures
US6711436B1 (en) 1997-08-08 2004-03-23 Duke University Compositions, apparatus and methods for facilitating surgical procedures
US6395758B1 (en) * 1998-08-14 2002-05-28 Gpi Nil Holdings, Inc. Small molecule carbamates or ureas for vision and memory disorders
US7220422B2 (en) * 2003-05-20 2007-05-22 Allergan, Inc. Methods and compositions for treating eye disorders
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
WO2011058366A1 (en) 2009-11-12 2011-05-19 Acacia Pharma Limited Use of bethanechol for treatment of xerostomia
AR104177A1 (es) * 2015-04-03 2017-07-05 Santen Pharmaceutical Co Ltd Sistema para la administración de fármacos en la glándula lagrimal

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2185220A (en) * 1938-08-17 1940-01-02 Smith Kline French Lab Medicinal agent
GB1386864A (en) * 1972-02-11 1975-03-12 Avicon Inc Micro-crystalline collage-containing pharmaceutical compositions useful for topical applications
EP0316345A1 (en) * 1986-07-28 1989-05-24 Liposome Technology, Inc. Liposomes with enhanced retention on mucosal tissue
US4804539A (en) * 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes

Also Published As

Publication number Publication date
FI108516B (fi) 2002-02-15
HU221592B (hu) 2002-11-28
FI940637A0 (fi) 1994-02-11
EP0661968A1 (en) 1995-07-12
ATE172114T1 (de) 1998-10-15
DK0661968T3 (da) 1999-06-23
AU671805B2 (en) 1996-09-12
SE9102340D0 (sv) 1991-08-13
DE69227324T2 (de) 1999-04-29
HUT65946A (en) 1994-08-29
NO940400D0 (no) 1994-02-07
CA2114239A1 (en) 1993-02-14
NO940400L (no) 1994-02-07
HU9400405D0 (en) 1994-05-30
US5679713A (en) 1997-10-21
WO1993003718A1 (en) 1993-03-04
CA2114239C (en) 2003-10-21
EP0528776A1 (en) 1993-02-24
EP0661968B1 (en) 1998-10-14
DE69227324D1 (de) 1998-11-19
JPH06509801A (ja) 1994-11-02
AU2463192A (en) 1993-03-16
NO306447B1 (no) 1999-11-08
ES2123005T3 (es) 1999-01-01

Similar Documents

Publication Publication Date Title
ATE184598T1 (de) Enniatine und enniatinderivate zur bekämpfung von endoparasiten
ATE203019T1 (de) Neue (r)-5-carbamoyl-8-fluor-3-n,n- disubstituierte-amino-3,4-dihydro-2h-1- benzopyrane
PT100963A (pt) Composicoes farmaceuticas para aplicacao topica de elevada penetracao atraves da pele que compreendem certos polimeros nao-ionicos especificos
EP0765160A4 (fi)
KR880012218A (ko) 캘폰 유도체를 사용한 다발성 경화증의 치료방법
DE69531098D1 (de) Piperidine und pyrrolidine
ES2045182T3 (es) Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen.
NO902800L (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
ES2173858T3 (es) Analogos de huperzina a.
FI940637A (fi) Karbakolia ja muita kolinergisiä substansseja sisältävä farmaseuttinenkoostumus
BR9500436A (pt) Produtos uso de um g-csf uso de uma proteína tnf ligante processo para o tratamento e/ou prevenção do choque séptico
NO934832D0 (no) Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose
AU6278680A (en) Carbamates and pharmaceutical formulations containing them
ATE69381T1 (de) Anwendung exogener ganglioside zur herstellung eines arzneimittels zur anwendung bei tumorkrankheiten als schutzmittel gegen die toxizitaet tumorhemmender arzneimittel.
DK116386A (da) Polyprenylforbindelser, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
DE68901656D1 (de) Pharmazeutische zusammensetzung zur milderung der nebenwirkungen von platinhaltigen arzneimitteln.
MX9203900A (es) Composicion farmaceutica que comprende derivados de acido benzimidazolin-2-oxo-1-carboxilico.
BR9106596A (pt) Processo para o tratamento ou profilaxia de uma infeccao associada com retrovirus,uso,composicao farmaceutica para o tratamento ou profilaxia de uma infeccao associada com retrovirus,e,composto
DE3484155D1 (de) Fr-900216-verbindung, durch kultivierung von atcc 20577 gewonnen, als aktive therapeutische verbindung genutzt, und sie enthaltende antitumorale pharmazeutische zusammensetzung von fr-900216.
IL89015A (en) Pharmaceutical compositions containing tetrahydropyridine derivatives, certain such novel compounds and their preparation
BG95724A (en) Medicaments with analgetic, antiphlogestic and antibacterial effect for external use
SE9203296D0 (sv) The use of inositoltrisphate for the preparing of medicaments
UA7180C2 (uk) Препарат для лікування та профілактики атерогенних дисліпопротеїнемій та синдрому гіперкоагуляції
ATE32514T1 (de) 3-(4'-aminobutylamino)-propylamino-bleomycinderivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ITMI932219A1 (it) Composizioni farmaceutiche contenenti una sostanza attiva fosfatidilinositolo atte alla terapia delle neurpatie periferiche da

Legal Events

Date Code Title Description
MA Patent expired